Keys To Success: Maniacal Focus And Adaptive Readiness

 
• By David Wild

With an engineer’s mind, Jason Park, CEO of Empress Therapeutics, has a unique take on problem solving for fundraising and the value of being a platform company focused on small molecules.

formula
Jason Park Says Small Molecules Have A Host Of Advantages Over More Advanced Therapies • Source: Shutterstock

More from Rising Leaders

More from Leadership